-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Elevance Health, Raises Price Target to $523

Benzinga·10/22/2026 19:51:42
Listen to the news
UBS analyst A.J. Rice maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $460 to $523.